Literature DB >> 199964

alpha-L-Iduronidase activity in established lymphoblastoid cells from patients with Hurler and Scheie syndromes transformed by Epstein-Barr virus.

R Minami, M Suzuki, T Kudoh, S Sato, K Oyanagi.   

Abstract

alpha-L-Iduronidase activity was determined in established lymphoblastoid cells, which were transformed in vitro by Epstein-Barr virus, of lymphocytes-rich cell populations isolated from peripheral blood of patients with Hurler and Scheie syndromes. alpha-L-Iduronidase activities in established lymphoblastoid cells from patients were undetectable, while activities of control subjects were clearly detected. These results suggest that established lymphoblastoid cells are useful for the enzymatic study of genetic mucopolysaccharidoses.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 199964     DOI: 10.1620/tjem.122.393

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

1.  Sphingomyelinase activities in cultured skin fibroblasts from patients with Niemann-Pick Disease.

Authors:  R Minami; Y Matsuura; F Nakamura; T Kudoh; H Sogawa; K Oyanagi; K Sukegawa; T Orii; K Maruyama; T Nakao
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases.

Authors:  A S de Mello; F Provin; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

3.  Lysosomal acid hydrolases in established lymphoblastoid cell lines, transformed by Epstein-Barr virus, from patients with genetic lysosomal storage diseases.

Authors:  R Minami; Y Watanabe; T Kudoh; M Suzuki; K Oyanagi; T Orii; T Nakao
Journal:  Hum Genet       Date:  1978-10-19       Impact factor: 4.132

4.  Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders--enumerative conditions for cryopreservation.

Authors:  A S Mello; M G Burin; K Michellin; M Viapiana; R Giugliani; J C Coelho; M E Bauer
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

5.  LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.

Authors:  A S Mello; M P Goldim; J Mezzalira; C S Garcia; V V Daitx; V V Daitz; C D Castilhos; M S Viegas; O V Vieira; J C Coelho
Journal:  Mol Cell Biochem       Date:  2013-09-26       Impact factor: 3.396

6.  Effect of one year of cryopreservation on the activity of lysosomal hydrolases from EBV-transformed lymphocytes.

Authors:  A S de Mello; F B Mendes; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  J Biomed Biotechnol       Date:  2011-05-19

Review 7.  Emerging Approaches for Fluorescence-Based Newborn Screening of Mucopolysaccharidoses.

Authors:  Rajendra Singh; Shaileja Chopra; Carrie Graham; Melissa Langer; Rainer Ng; Anirudh J Ullal; Vamsee K Pamula
Journal:  Diagnostics (Basel)       Date:  2020-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.